Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + Amodiaquine vs Artemether + Lumefantrine for Repeated Malaria Attacks
NCT00540410Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artesunate + amodiaquine in Plasmodium falciparum malaria, sponsored by Sanofi. Started Sep 2007; status: completed.
02
Drugs
artesunate + amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00540410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00540410.